Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 310.40% | -49.03% | -98.86% | -82.23% | -88.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 310.40% | -49.03% | -98.86% | -82.23% | -88.48% |
| Cost of Revenue | -68.81% | -30.11% | 17.59% | -15.84% | -92.31% |
| Gross Profit | 311.56% | -89.41% | -35.26% | -545.30% | 93.66% |
| SG&A Expenses | -30.84% | 13.14% | 20.69% | 5.84% | -15.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.33% | -22.67% | 18.43% | 54.14% | 12.03% |
| Operating Income | 47.29% | -43.40% | -30.91% | -63.07% | -31.46% |
| Income Before Tax | -22.82% | -140.52% | -38.03% | -67.80% | -26.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.82% | -140.52% | -38.03% | -67.80% | -26.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.82% | -140.52% | -38.03% | -67.80% | -26.34% |
| EBIT | 47.29% | -43.40% | -30.91% | -63.07% | -31.46% |
| EBITDA | 49.08% | -46.60% | -31.69% | -65.63% | -32.71% |
| EPS Basic | -21.16% | -137.88% | -36.63% | -45.51% | -6.28% |
| Normalized Basic EPS | 43.89% | -89.93% | -36.62% | -45.52% | -6.25% |
| EPS Diluted | -21.16% | -137.88% | -36.63% | -45.51% | -6.28% |
| Normalized Diluted EPS | 43.89% | -89.93% | -36.62% | -45.52% | -6.25% |
| Average Basic Shares Outstanding | 1.36% | 1.11% | 1.03% | 15.32% | 18.88% |
| Average Diluted Shares Outstanding | 1.36% | 1.11% | 1.03% | 15.32% | 18.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |